| |
|
|
|
|
|
Intended Use The Wako Autokit CH50 is an in vitro liposome immunoassay (LIA) for the quantitative determination of total complement activity (CH50) in human serum using an automated procedure.
Associated
Medical Conditions Immunology
Method Liposome immunoassay
Assay Linearity 10 - 65 U/mL
Basic Procedure Sample: 10 µL
R1: 250 µL
R2: 125 µL
Wavelength: main: 340 nm, sub: 700 nm
|
Company:
Date:
December 10, 2008
|
|
|
|
|
|
|
|
|
|
The questions regarding your methods should be answered as fully as possible, using the METHOD QUESTIONNAIRE. Your answers
will help us to place your result for each analyte into the correct category and thus provide you with useful statistical data.
This document is to be kept as your permanent record. It is also used to complete the ENROLMENT DOCUMENT.
|
Company:
Date:
December 10, 2008
|
|
|
|
|
|
|
|
|
|
Total Cholesterol is used as a predictor of cardiovascular disease risk
|
Company:
Date:
December 10, 2008
|
|
|
|
|
|
|
|
|
|
Dimension-Dade Behring reagents
|
Company:
Date:
December 10, 2008
|
|
|
|
|
|
|
|
|
|
Plasma lipoproteins are spherical particles that contain varying amounts of cholesterol, triglycerides, phospholipids, and proteins. The phospholipid, free cholesterol and protein constitute the outer surface of the lipoprotein particle; the inner core contains mostly esterified cholesterol and triglycerides. These particles serve to solubilize and transport cholesterol and triglycerides in the bloodstream.
The relative proportions of protein and lipid determine the density of these plasma lipoproteins and provide a basis for their classification. The classes are: very low density lipoproteins
|
Company:
Date:
December 10, 2008
|
|
|
|
|
|
|
|
|
|
Intended Use The Wako Free Cholesterol E is an in vitro assay for the quantitative determination of free cholesterol in serum.
Associated
Medical Conditions Cardiovascular Disease
Method Enzymatic
Assay Linearity Up to 300 mg/dL
Basic Procedure Sample: 50 µL
R1: 3 mL
Wavelength: 600 nm
Bichromatic Wavelength: main: 600 nm, sub: 700 nm
|
Company:
Date:
December 10, 2008
|
|
|
|
|
|
|
|
|
|
The HDL and LDL Cholesterol reagents are compatible with fasting and non-fasting samples with no significant interference from Triglycerides up to 1000 mg/dL. For simplified sample processing, no pre-treatment is required and the direct measurement of serum or plasma specimens eliminates the extra time and costs associated with sample splitting. The reagents are ready-to-use liquid formulations available in two convenient kit sizes with Olympus bar-coded cartridges that allow on-board reagent management. Other features include 30-day on-board stability and 30-day calibration stability.
|
Company:
Date:
December 10, 2008
|
|
|
|
|
|
|
|
|
|
Liquid-stable, ready-to-use reagent
Selective direct single measurement
Endpoint assay
Linearity up to 400 mg/dL
Wavelength 600 nm / 700 nm (bichromatic)
|
Company:
Date:
December 10, 2008
|
|
|
|
|
|
|
|
|
|
Liquid-stable, ready-to-use reagent
Selective direct single measurement
Endpoint assay
Linearity up to 400 mg/dL
Wavelength 600 nm / 700 nm (bichromatic)
|
Company:
Date:
December 10, 2008
|
|
|
|
|
|
|
|
|
|
Liquid-stable, ready-to-use reagent
Selective direct single measurement
Endpoint assay
Linearity up to 400 mg/dL
Wavelength 600 nm / 700 nm (bichromatic)
|
Company:
Date:
December 10, 2008
|
|
|
|
|
|